Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics

Novel unbiased, in situ Spatial Single-Cell Metabolomics (SSCM) enables high-throughput metabolic tissue characterization with single-cell resolution New 5 µm microGRID™ technology for timsTOF® fleX MALDI mode provides virtually artifact-free small-molecule images across large field of view Novel 4D-Metabolomics methods use CCS-Predict Pro AI/DL to enrich lipids, metabolite, and glycan libraries with molecular collision cross sections... Read more

Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022

MUNICH–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) this week displays its high-value scientific instrumentation, software and integrated solutions for applications in materials and energy research, biopharmaceuticals, applied markets, as well as life science and translational research at Analytica 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220621005512/en/ HYPERION II FT-IR / IR Laser... Read more

PerkinElmer and Novartis Collaborate to Address the Unmet Need of Sickle Cell Disease in Sub-Saharan Africa

PerkinElmer’s contributions to the Novartis Africa Sickle Cell Disease program will accelerate access to sickle cell disease screening and treatment across the continent WALTHAM, Mass. – June 16, 2022 – PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced that it is collaborating with Novartis, a leading global medicines company,... Read more

PerkinElmer to Host International Summit on Newborn Screening

Virtual event will convene a global audience to explore new approaches and novel technologies used to help newborns get a healthier start to life WHAT: PerkinElmer Inc., a global leader committed to innovating for a heathier world, will host a three-day scientific event exploring the latest advances in newborn screening programs and related technologies. Organized... Read more

Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope

New NeuraLight 3D Ultra Module Expands Neuroscience Research Capabilities MADISON, Wis.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the release of the NeuraLight 3D Ultra™module to support advanced neuroscience and optogenetics research applications on Bruker’s Ultima multiphoton microscopes. NeuraLight 3D Ultra provides revolutionary 3D holographic photostimulation, specifically optimized for functional and large-scale studies of neural... Read more

EUROIMMUN Launches Two Assays for the Quantification of SARS-CoV-2 Antibodies

CE-marked antibody tests expand EUROIMMUN’s comprehensive portfolio of laboratory products to support the analysis of the immune response to COVID-19 Waltham, MASS. – June 13, 2022 – EUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of two CE marked assays – the Anti-SARS-CoV-2 RBD ChLIA (IgG) and the Anti-SARS-CoV-2 Omicron ELISA (IgG). Both test... Read more

PerkinElmer Expands Food Safety Testing Portfolio with AOAC Certified Microbial Count Plates

Fast, easy, accurate MicrofastTM microfilm plates identify contaminants across multiple sample types WALTHAM, Mass. – June 7, 2022 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the global availability of its ready to use, MicrofastTM microbial count plates for food safety testing. The new microfilm plates are designed... Read more

PerkinElmer Launches BioQule NGS System to Automate Library Preparation

Affordable, easy-to-use benchtop system empowers labs of all sizes to both generate and quality control NGS libraries for genomic analysis WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 6, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the launch of the research use only (RUO) BioQule™ NGS System – an automated... Read more